Detailed Narrative
Q3 FY26 Financial Performance and Margin Improvement
In Q3 FY26, Gem Aromatics reported consolidated revenue from operations of INR 78.9 crores. Despite a net loss of INR 5 crores, primarily due to higher depreciation, the company demonstrated significant margin improvement. Consolidated Gross Profit margin expanded from 14% in Q2 FY26 to 23% in Q3 FY26, while consolidated EBITDA margin improved from 3% to 8.9% quarter-on-quarter. This margin expansion was attributed to improved realizations, a gradual recovery in mint prices, and better customer alignment.
Dahej Greenfield Facility Commissioning and Capacity Expansion
The company made significant progress at its Greenfield Dahej facility, which is a key pillar for long-term growth. The facility commissioned cooling agents (WS23 and WS03) and clove/eugenol verticals on December 11, 2025. With a total capital expenditure of approximately INR 270 crores (INR 250 crores already incurred), the Dahej plant will increase the company's total capacity to 16,000 MTPA, representing an effective 3x expansion. The plant has also successfully completed first-stage audits for various global compliance certifications.
Product Diversification and Phenol Derivatives Strategy
Gem Aromatics is expanding beyond its mint-centric business towards a diversified specialty ingredients platform. The Dahej facility will enable manufacturing capabilities across Clove and Clove Derivatives, Citral Derivatives, Phenol Derivatives, and Cooling Agents. For Phenol Derivatives, catalyst preparation is expected to be completed by Q4 FY26, with trial production of Anisole, MEHQ, and Guaiacol planned for Q1 FY27. The company intends to manufacture Anisole in-house to gain cost advantages for downstream products, focusing on margin-accretive derivatives for the flavor and fragrance industry.
Market Headwinds and Mitigation Strategies
Revenues in Q3 FY26 were impacted by external headwinds🌐, including tariff-related uncertainty and GST-related changes, which influenced customer procurement behavior. The company noted that approximately 60% of its FY25 exports to the US market were under tariffs, causing pain. To mitigate these risks, Gem Aromatics is pursuing a 'dual US plus one' strategy, focusing on tariff-exempt products for the US and expanding exposure to the European markets, anticipating benefits from the India-EU trade deal.
Long-term Growth Outlook and Targets
The company is confident in its growth trajectory, targeting revenue of INR 1,050-1,100 crores by FY28, with EBITDA margins in the range of 16-18%. The Dahej facility is expected to reach 50-60% utilization by Q1 FY28 and generate INR 750-800 crores in revenue by FY29, based on a 3x asset turnover. Krystal (Dahej) is projected to achieve cash breakeven by FY27 at approximately 45% capacity utilization, contributing INR 650-700 crores to the FY28 revenue target, with the remaining INR 400 crores from existing GEM facilities.